About Us

The National Center for Health Research analyzes and explains the latest research-based information that patients, policy makers, and the public can use to improve their own health and to develop better health programs and policies.   The U.S. has the most expensive healthcare in the world, but we don’t live as long as men and women in Europe, Australia, or Canada.

To read more about us, check for job openings and more, click here.

In The News

The FDA Needs to Pull Failed Drugs From the Market December 3, 2016 – Some drugs get to market before proving their clinical worth. Why are they still sold after failing later tests? NCHR says the FDA is to blame. Continue reading
To fund projects like the Cancer Moonshot, Congress had to strip away some of the FDA’s most important regulatory powers The 21st Century Cures Act passed in the House, but comes with a lot of regulatory compromise and threats to patient safety. Most notably, Senator Warren and Senator Sanders oppose the bill along with NCHR President Diana Zuckerman due to patient safety concerns and breaks for Big Pharma. “It really is a David and Goliath issue of where the money is,” said Dr. Zuckerman. Continue reading
Cancer drugs may remain approved despite lack of benefit Reuters, December 1, 2016. Researchers evaluated studies done on 18 cancer drugs approved between 2008 and 2012 by the FDA. None of the drugs had been found to prolong life, and only one had enough evidence to say it improved quality of life. Yet, all but one retained its approval status. Continue reading
Why the 21st Century Cures Act could be Disastrous for Medicine Why would anyone vote against “cures,” especially “21st century cures?” Here’s why many health policy and consumer advocacy groups — including the National Center for Health Research — strongly oppose the bill and are asking senators not to pass the bill next week. Continue reading
New study explains why so many cancer drugs don’t work Why do some drugs stop cancer from growing within a few months and even make it begin to shrink, but ultimately don’t seem to help the patient live longer? Continue reading


Thanks to everyone who participated in our Introductory Patient Training Workshop on October 14-15, 2016, in Washington, D.C! If you’re interested in future workshops, check out our website: www.usapatientnetwork.org

URGENT: Contact your Member of Congress Now!

With support from Big Pharma, Congress is planning to pass a law that would lower the standards for new medical products. Congress says it will benefit patients, but to be a “cure” a treatment should actually help patients, not just enrich stockholders.

If you want safe medications instead of expensive, ineffective ones, please take 5 minutes to make this call. To learn more about the problems with this bill, click here.

What You Need To Know

Misleading Drug Ads

Do you think drug ads are providing helpful information or selling us a fantasy about miracle cures?

Latest Study Results of Essure Contraceptive

See our 2015 survey results about problems with Essure permanent birth control.

Letters to Annie

Find out about our #LetterstoAnnie project. What killed Annie, a healthy young woman? How can you protect yourself or your daughter? Each week, we will unravel the mystery through letters from Annie’s mom to her daughterwww.letterstoannie.org

Some Contraceptives Are Safer Than Others 

If you or a loved one have been harmed by a birth control pill or implant, click here.

Patient Advocacy Workshop

Patient advocates from across the country joined us for a day of training to learn more about the FDA process and how patients can have their voices heard.

Is that Screening Necessary? Physician Experts Say Maybe Not

25 major medical groups recommended which medical tests you DON’T need.  Why pay for tests that might even hurt you?

What You Need to Know About YAZ Birth Control

YAZ, Yasmin, Beyaz, and other drospirenone hormonal birth control pills have been found to put women at an increased risk for serious blood clots. Read why. Or read about all your birth control options.

For updates on what we’ve been up to at the NCHR, follow us on Twitter and like us on Facebook.